K
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A42.7 KBKinnate Biopharma Inc.Nov 13, 2:59 PM ET·0001193125-24-257099
- SC 13D/A123.5 KBKinnate Biopharma Inc.Apr 5, 4:15 PM ET·0000950142-24-000986
- 8-K373.4 KBKinnate Biopharma Inc.Apr 3, 9:28 AM ET·0001193125-24-085548
- 10-K10.5 MBKinnate Biopharma Inc.Mar 28, 4:12 PM ET·0001140361-24-016132
- 8-K1.8 MBKinnate Biopharma Inc.Mar 1, 8:50 AM ET·0001140361-24-010648
- SC 13D/A265.9 KBKinnate Biopharma Inc.Feb 22, 4:39 PM ET·0000950142-24-000519
- SC 13D/A219.2 KBKinnate Biopharma Inc.Feb 21, 4:11 PM ET·0000947871-24-000181
- 8-K1.5 MBKinnate Biopharma Inc.Feb 16, 9:10 AM ET·0001140361-24-008282
- SC 13G/A90.9 KBKinnate Biopharma Inc.Feb 14, 4:16 PM ET·0001104659-24-023668
- SC 13G/A84.2 KBKinnate Biopharma Inc.Feb 14, 4:00 PM ET·0001214659-24-002873
Insiders
10- DeSimone JillDirector
- Epperly Melissa B,Director
- Farzan NimaDirector, President and CEO
- Flaherty Keith T.Director
- Foresite Capital Fund IV, L.P.10% Owner
- Foresite Capital Fund V, L.P.10% Owner
- Foresite Capital Management IV, LLC10% Owner
- Foresite Capital Management V, LLC10% Owner
- Foresite Capital Opportunity Fund V, L.P.10% Owner
- Foresite Capital Opportunity Management V, LLC10% Owner
Tickers
No tickers on record
Addresses
business
11975 EL CAMINO REAL, STE 101
SAN DIEGO, CA, 92130
mailing
11975 EL CAMINO REAL, STE 101
SAN DIEGO, CA, 92130